By clarifying code specifications, including new formulations, and standardizing billing practices, these changes ensure accurate and efficient billing processes
First approved by the FDA for type 2 diabetes, they have since altered how clinicians approach obesity treatment, swiftly changing hundreds of thousands of lives (Conley, 2025)
Conclusions Following the initiation of semaglutide, other GLP-1 agonists, or GLP-1/GIP dual agonists, practitioners should be aware of the potential severe complications, such as colonic ischemia, and properly educate their patients about these risks
A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
Due to the higher bioavailability, injectable PDA can often achieve more potent and rapid effects